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ABSTRACT 
Background: Molecular docking has tremendous applications in the field of Siddha medicine 
especially herbal formulations were the interactions of the lead molecules of the formulation with 
that of receptors can be elucidated at the molecular level and furthermore to reach an assumption 
of its fundamental biochemical processes to which the formulation is targeting. Kuppaimeni 
Choornam (KC) is a simple herbal formulation used in Siddha medicine for urticaria and other skin 
allergies. As far as skin allergy is concerned Amino acids such as Asparagine (ASN), Tryptophan 
(Trp), Aspartate (Asp), Tyrosine (Tyr), Serine (Ser), Isoleucine (Ile), Lysine (Lys), Threonine (Thr), 
Phenylalanine (Phe) are the main core residues involved in mediating Human histamine receptor 
(3RZE). Binding of lead compounds with this core residue may inhibit the enzyme activity. Aim & 
Objectives: Molecular docking studies of Siddha herbal formulation KC and to screen the lead 
component interaction on the Human Histamine Receptor (3RZE). Methodology: Docking 
calculations were carried out using Auto Dock 4. Gasteiger partial charges were added to the 
ligand atoms. Docking simulations were performed using the Lamarckian genetic algorithm (LGA) 
and the Solis & Wets local search method. Initial position, orientation, and torsions of the ligand 
molecules were set randomly. All rotatable torsions were released during docking. Results and 
Conclusion: The compounds present in KC like beta-sitosterol, apigenin, luteolin, cuminaldehyde, 
kaempferol, and triacetonamine showed maximum interactions with 3RZE when compared to that 
of the standard cetirizine. Hence, these compounds of test drug possess promising Human 
histamine 1 receptor (3RZE) inhibition activity. For prospective pharmacological validation of 
Kuppaimeni Choornam, the docking studies were an important step for its scientific justification. 
KEYWORDS: Siddha medicine, Kuppaimeni Choornam, Human histamine receptor (3RZE), 
Molecular docking. 
INTRODUCTION 
Urticaria is a clinical condition characterized 
by wheal or angioedema or both anywhere in the 
body due to multiple factors.[1] The condition is 
broadly classified into two based on the duration of 
occurrence of the symptoms. Urticaria of sudden 
origin is most frequently a self-limited disorder 
caused by an allergic reaction to a food or drug and 
which have duration less than 6 weeks. If the 
symptoms persist continuously or show recurrences 
for more than 6 weeks, it is termed as chronic 
urticaria.[2] Chronic idiopathic urticaria (CIU) yet 
another common clinical presentation related to 
autoimmunity.[1] The main pathogenesis is better 
understood with the central role of histamine release 
and mast cell degranulation, which are the main 
triggering factors responsible for the sequence of 
clinical events occurring in urticaria.[1-3] 
All the symptoms of urticaria are mostly 
mediated through H1 receptors (Human histamine 
receptor- 3RZE) and therefore in a modern approach, 
drugs of non-sedating Anti-histamine category is 
effectively used for its management.[4] There are 
numerous amino acids responsible for mediating the 
3RZE. The drugs or biomolecules that effectively 
targets the core residues block the receptor activity 
ultimately controls the symptoms of urticaria. [4, 5] 
In traditional Siddha medicine, the clinical 
picture of urticaria is more or less correlated with the 
condition called ‘Silvidam’. Numerous herbal or 
herbomineral formulations are exclusively given for 
the condition. Kuppaimeni Choornam (KC) is one 
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among the herbal medicine used for classical 
urticarias and allergic conditions. The formulation is 
mentioned in the Tamil medical text Agathiyar 
paripooranam 400.[6] Acalypha indica and Cuminum 
cyminum are the main ingredients of this herbal 
combination. For a wider research perspective, the 
lead molecules of this formulation were interpreted 
for its Human histamine receptor - 3RZE inhibitor 
activity. This may help in wider acceptability of KC as 
an efficient Anti urticarial or anti- allergic herbal 
formulation. 
 
 
 
 
 
Aim and Objectives 
The main objective of the study is to carry out 
Molecular Docking (MD) studies of lead molecules 
from key ingredients of KC to find its interaction on 
Human Histamine Receptor (3RZE).  
METHODOLOGY 
Lead Molecules from KC 
Docking calculations were carried out for the 
compounds retrieved from the herbal sources such as 
carvone, beta pinene, beta-sitosterol, gamma 
terpinene, apigenin, carvacrol, luteolin, 
cuminaldehyde, kaempferol, cymene, triacetonamine, 
and their respective standard cetirizine[7] against 
target protein model (Table. 1 & Fig A). The ligand 
molecular properties are illustrated in Table. 2.  
Table: 1 List of Lead Molecules selected for docking studies 
S.No Name of the Herb Phytocomponents 
1. Acalypha indica (Whole plant) Beta Sitosterol 
Triacetonamine 
2. Cuminum cyminum (Seed) Cuminaldehyde 
Beta Pinene 
Cymene 
Carvone 
Carvacrol 
Gamma-Terpinene 
Luteolin 
Kaempferol 
 
 
Carvone 
 
Beta Pinene 
 
Beta Sitosterol 
 
Gamma Terpinene 
 
Apigenin 
 
Carvacrol 
 
Luteolin 
 
Cuminaldehyde 
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Kaempferol 
 
Cymene 
 
Triacetanomine 
 
Cetirizine 
Fig: A. 2D And 3D Structure Of Lead Compounds 
 
Table: 2 Ligand Properties of the compounds from KC selected for docking 
Compound Molecular 
Formula 
Molar weight 
g/mol 
H Bond 
Donor 
H Bond 
Acceptor 
Rotatable 
bonds 
Log P 
Carvone C10H14O 150.221 g/mol 0 1 1 2.4 
Beta Pinene C10H16 136.238 g/mol 0 0 0 3.1 
Beta Sitosterol C29H50O 414.718 g/mol 1 1 6 9.3 
Gamma Terpinene C10H16 136.238 g/mol 0 0 1 2.8 
Apigenin C15H10O5 270.24 g/mol 3 5 1 1.7 
Carvacrol C10H14O 150.221 g/mol 1 1 1 3.1 
Luteolin C15H10O6 286.239 g/mol 4 6 1 1.4 
Cuminaldehyde C10H12O 148.205 g/mol 0 1 2 2.7 
Kaempferol C15H10O6 286.239 g/mol 4 6 1 1.9 
Cymene C10H14 134.222 g/mol 0 0 1 4.1 
Triacetanomine C9H17NO 155.241 g/mol 1 2 0 0.5 
Cetirizine C21H27Cl3N2O3 461.808 g/mol 3 5 8 0 
Target details and Receptor Structure  
The crystalline structure of the target protein Human Histamine Receptor (3RZE)was retrieved from 
protein data bank and protein clean-up process was done and essential missing hydrogen atom was been 
added. (Fig. B) Different orientation of the lead molecules with respect to the target protein was evaluated by 
Auto-dock program and the best dock pose was selected based on the interaction study analysis. 
  
 
Fig. B.Target details and Receptor Structure of Human Histamine 1 Receptor – 3RZE 
Tool for Study[8-9] 
Docking calculations were carried out using Auto Dock 4. Gasteiger partial charges were added to the 
ligand atoms. Non-polar hydrogen atoms were merged, and rotatable bonds were defined. Essential hydrogen 
atoms, Kollman united atom type charges, and solvation parameters were added with the aid of Auto-dock tools 
(Morris, Goodsell, et al., 1998). Affinity (grid) maps of ×× Å grid points and 0.375 Å spacing were generated using 
the Autogrid program (Morris, Goodsell, et al., 1998). Auto-dock parameter set- and distance-dependent 
dielectric functions were used in the calculation of the van der Waals and the electrostatic terms, respectively.  
Docking simulations were performed using the Lamarckian genetic algorithm (LGA) and the Solis & 
Wets local search method (Solis and Wets, 1981). Initial position, orientation, and torsions of the ligand 
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molecules were set randomly. All rotatable torsions were released during docking. Each docking experiment 
was derived from 2 different runs that were set to terminate after a maximum of 250000 energy evaluations. 
The population size was set to 150. During the search, a translational step of 0.2 Å, and quaternion and torsion 
steps of 5 were applied. 
Results 
The compounds beta-sitosterol apigenin, luteolin, cuminaldehyde, kaempferol and triacetonamine have 
maximum interactions with when compared to that of the standard Cetirizine. Hence, these compounds of test 
drug possess promising Human histamine 1 receptor (3RZE) inhibition activity. The Summary of the molecular 
docking studies of the lead compounds and standard Cetirizine against 3RZEand its amino acid binding 
interactions have been tabulated in Table. 3 & 4, and Fig C. 
Table: 3 Summary of the molecular docking studies of the DC lead compounds against 
Human histamine 1 receptor (3RZE) 
Compounds Binding Free 
energy 
Kcal/mol 
Inhibition constant 
Ki µM (*mM)(**nM) 
Total 
Intermolecular 
energy (Kcal/mol) 
Total 
Interaction 
Surface 
Carvone -6.54 16.12 -0.01 -6.84 
Beta Pinene -6.26 25.66 0.01 -6.26 
Beta Sitosterol -5.79 57.06 -0.09 -8.07 
Gamma Terpinene -5.91 46.68 0 -6.21 
Apigenin -8.28 853.19** -0.28 -8.82 
Carvacrol -7 7.46 -0.13 -7.86 
Luteolin -9.01 248.17** -0.45 -9.29 
Cuminaldehyde -5.91 46.63 -0.02 -6.51 
Kaempferol -7.25 4.83 -0.28 -7.81 
Cymene -6.47 18.09 0 -6.77 
Triacetonamine -5.93 44.91 1.4 -5.93 
Cetirizine -10.56 18.16** -0.72 -12.71 
 
 
Fig: C. Amino acid Residue Interaction of Lead and Standard against Human histamine 1 receptor 
(3RZE) 
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Interaction Analysis HB - Plotting analysis  
(Hydrogen Bond formation)  
Carvone with Human histamine 1 receptor (3RZE) 
 
Interaction Analysis HB - Plotting analysis  
(Hydrogen Bond formation)  
Pinenewith Human histamine 1 receptor (3RZE) 
 
Interaction Analysis HB - Plotting analysis  
(Hydrogen Bond formation)  
Betasitosterol with Human histamine 1 receptor (3RZE) 
 
Interaction Analysis HB - Plotting analysis 
(Hydrogen Bond formation)  
Gamma triterpene with Human histamine 1 receptor (3RZE) 
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Interaction Analysis HB - Plotting analysis 
(Hydrogen Bond formation) 
 
Apigenine with Human histamine 1 receptor (3RZE) 
 
Interaction Analysis HB - Plotting analysis 
(Hydrogen Bond formation)  
Carvacrol with Human histamine 1 receptor (3RZE) 
 
Interaction Analysis HB - Plotting analysis 
(Hydrogen Bond formation) 
 
Luteolin with Human histamine 1 receptor (3RZE) 
 
Interaction Analysis HB - Plotting analysis 
(Hydrogen Bond formation) 
 
Cuminaldehyde with Human histamine 1 receptor (3RZE) 
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Interaction Analysis HB - Plotting analysis 
(Hydrogen Bond formation)  
Kaempferol with Human histamine 1 receptor (3RZE) 
 
Interaction Analysis HB - Plotting analysis 
(Hydrogen Bond formation)  
Cymene with Human histamine 1 receptor (3RZE) 
 
Interaction Analysis HB - Plotting analysis 
(Hydrogen Bond formation) 
 
Triacetonamine with Human histamine 1 receptor (3RZE) 
 
 
Interaction Analysis HB - Plotting analysis 
(Hydrogen Bond formation) 
 
Cetirizine with Human histamine 1 receptor (3RZE) 
Fig. D. Amino acid interactions of Lead molecules of DC and standard 
DISCUSSION 
Urticaria is a common clinical manifestation 
occurring due to a multitude of factors and mostly 
termed as a mast cell-driven disease. As symptomatic 
relief is the primary aim of its management, the 
fundamental of the drug therapy in modern medicine 
is to reduce the effects of mediators of mast cells such 
as histamine, platelet aggravating factors, and others 
on the target organs. The biogenic amine called 
histamine exerts its effect by eventually acting on the 
four G- Protein-Coupled Receptors (GPCR). Histamine 
receptors (H1R) are one among the important GPCR 
located in the endothelial cells and sensory nerves 
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that has a crucial role in regulating inflammatory and 
allergic responses occurring in the human system. 
Due to its prime importance, H1R is the main target of 
drugs included in the Anti-histamine category. Many 
of the second-generation nonsedating H1receptor 
antagonists like cetirizine and levocetirizine are very 
popular due to their safety profile and been used as 
the first line of management in most of the urticarial 
conditions. [10 - 11] 
In traditional siddha medicine (TSM), there 
are numerous herbal formulations, which are used as 
first order preferences in most of the urticarial 
conditions. Urticarial symptoms are more or less 
correlated with the clinical picture of Siddha 
diagnostical term Silvidam, characterized by the 
sudden or progressive development of inflammatory 
rashes (wheals) throughout the body or in particular 
places with accompanying itching, burning or even 
pain. The etiology is multidimensional mostly 
occurring due to toxic bites, adverse drug reactions, 
food incompatibilities, and allergies. Single or 
compound formulations are prescribed accordingly 
with the severity. The ancient concepts of drug 
administration are truly based on body nature 
(Deham), nature of pulse (Nadi) and the clinical 
presentations of the particular condition. The type 
and form of medicines are selective, considering the 
above criteria. [12-14] 
Kuppaimeni Choornam (KC) is a simple herbal 
combination indicated for classical urticarias. Dried 
Kuppaimeni (Acalypha indica- whole plant) and 
Jeeragam (Cuminum cyminum) are the key 
ingredients. In the previous clinical background, the 
drug in powder form was observed effective at doses 
2-5 g thrice or four times a day for reducing the 
symptoms of most of the skin allergies, rashes due to 
insect bites or urticarial conditions due to unknown 
reasons.[6] Acalypha and cuminum has been proved 
for its Anti-inflammatory effects in many of the 
recent studies.[15-19] 
Molecular docking is a widely accepted tool, 
which allows the researcher to predict the 
pharmacological efficiency of a drug or formulations. 
This approach has tremendous applications in the 
field of Siddha medicine especially herbal 
formulations were the interactions of the lead 
molecules of the formulation with that of receptors 
can be elucidated at the atomic level and furthermore 
to reach an assumption of its fundamental 
biochemical processes to which the formulation is 
targeting. [20-21] As far as skin allergy is concerned 
amino acids such as asparagine (Asn), tryptophan 
(Trp), aspartate (Asp), tyrosine (Tyr), serine (Ser), 
isoleucine (Ile), lysine (Lys), threonine (Thr), 
phenylalanine (Phe) are the main core residues 
involved in mediating Human histamine receptor 
(3RZE). Binding of lead compounds with this core 
residue may inhibit the enzyme activity. The lead 
molecule from both the ingredients was selected for 
the docking studies with comparative standard 
cetirizine. Most of the molecules have proven records 
as an anti-allergic, antihistamine, anti-prostaglandin 
or anti-inflammatory [22-24] (Table 4). Almost all the 
lead compounds had shown maximum interactions 
with H1R.  
Table: 4. Pharmacological significance of lead molecules from Kuppaimeni Choornam 
S.No Name of the Compound Pharmacological Activity 
1. Carvone Anti-inflammatory 
2. Beta Pinene Anti-inflammatory 
3. Beta Sitosterol Anti- Prostaglandin 
4. Gamma Terpinene Anti-inflammatory 
5. Apigenine Anti-histaminic, Anti-inflammatory 
6. Carvacrol Prostaglandin inhibitor, Anti-inflammatory 
7. Luteolin Anti-allergic, Anti-histaminic 
8. Cuminaldehyde Anti-inflammatory 
9. Kaempferol Anti-allergic, Anti histaminic 
CONCLUSION 
For prospective pharmacological validation of 
Kuppaimeni Choornam, the docking study was an 
important step for its scientific justification. The H1R 
antagonist effect of Kuppaimeni choornam further 
opens its wide clinical possibilities further 
supporting its traditional claim as a simple herbal 
remedy for classical urticarias. 
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